Increasing trend in enterococcal bacteraemia and vancomycin resistance in a tertiary care hospital in Croatia, 2017–2021

References

• Fisher K, Phillips C. The ecology, epidemiology and virulence of enterococcus. Microbiology. 2009;155(Pt 6):1749–1757.
   PubMed Web of Science ®Google Scholar
• Said MS, Tirthani E, Lesho E. Enterococcus infections. [Updated 2022 May 2]. In StatPearls. [Internet]. Treasure Island (FL): StatPearls Publishing; 2022. https://www.ncbi.nlm.nih.gov/books/NBK567759/
   Google Scholar
• Billington EO, Phang SH, Gregson DB, et al. Incidence, risk factors, and outcomes for enterococcus spp. bloodstream infections: a population-based study. Int J Infect Dis. 2014;26:76–82.
   PubMed Web of Science ®Google Scholar
• Mendes RE, Castanheira M, Farrell DJ, et al. Longitudinal (2001–14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010–13) analysis of oritavancin in vitro potency. J Antimicrob Chemother. 2016;71(12):3453–3458.
   PubMed Web of Science ®Google Scholar
• de Kraker ME, Jarlier V, Monen JC, et al. The changing epidemiology of bacteraemias in Europe: trends from the European antimicrobial resistance surveillance system. Clin Microbiol Infect. 2013;19(9):860–868.
   PubMed Web of Science ®Google Scholar
• Piezzi V, Gasser M, Atkinson A, et al. Swiss Centre for antibiotic resistance (ANRESIS); national Centre for infection control (Swissnoso). increasing proportion of vancomycin-resistance among enterococcal bacteraemias in Switzerland: a 6-year nation-wide surveillance, 2013 to 2018. Euro Surveill. 2020;25(35):1900575.
   PubMedGoogle Scholar
• Moses V, Jerobin J, Nair A, et al. Enterococcal bacteremia is associated with prolonged stay in the medical intensive care unit. J Global Infect Dis. 2012;4(1):26–30.
   PubMedGoogle Scholar
• Pinholt M, Ostergaard C, Arpi M, Danish Collaborative Bacteraemia Network (DACOBAN), et al. Incidence, clinical characteristics and 30-day mortality of enterococcal bacteraemia in Denmark 2006-2009: a population-based cohort study. Clin Microbiol Infect. 2014;20(2):145–151.
   PubMed Web of Science ®Google Scholar
• Noskin GA, Peterson LR, Warren JR. Enterococcus faecium and Enterococcus faecalis bacteremia: Acquisition and outcome. Clin Infect Dis. 1995;20(2):296–301.
   PubMed Web of Science ®Google Scholar
• Maki DG, Agger WA. Enterococcal bacteremia: clinical features, the risk of endocarditis, and management. Medicine. 1988;67(4):248–269.
   PubMed Web of Science ®Google Scholar
• Brinkwirth S, Ayobami O, Eckmanns T, et al. Hospital-acquired infections caused by enterococci: a systematic review and Meta-analysis, WHO European region, 1 January 2010 to 4 February 2020. Euro Surveill. 2021;26(45):2001628.
   PubMedGoogle Scholar
• Saenhom N, Boueroy P, Chopjitt P, et al. Distinguishing clinical Enterococcus faecium strains and resistance to vancomycin using a simple In-House screening test. Antibiotics (Basel. 2022;11(3):286.
   PubMed Web of Science ®Google Scholar
• Ayobami O, Willrich N, Reuss A, et al. The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections. Emerg Microb & Infect. 2020;9(1):1180–1193.
   PubMed Web of Science ®Google Scholar
• Rosselli Del Turco E, Bartoletti M, Dahl A, et al. How do I manage a patient with enterococcal bacteraemia? Clin Microbiol Infect. 2021;27(3):364–371.
   PubMed Web of Science ®Google Scholar
• Markwart1 R, Willrich N, Eckmanns T, et al. Low proportion of linezolid and daptomycin resistance Among bloodborne Vancomycin-Resistant Enterococcus faecium and Methicillin-Resistant Staphylococcus aureus infections in Europe. Front Microbiol. 2021;12:664199.
   PubMed Web of Science ®Google Scholar
• Egli A, Schmid H, Kuenzli E, et al. Association of daptomycin use with resistance development in Enterococcus faecium bacteraemia-a 7-year individual and population-based analysis. Clin Microbiol Infect. 2017;23(2):118.e1-118–e7.
   Web of Science ®Google Scholar
• Olearo F, Both A, Belmar Campos C, et al. Emergence of linezolid-resistance in vancomycin-resistant Enterococcus faecium ST117 associated with increased linezolid consumption. Int J Med Microbiol. 2021;311(2):151477.
   PubMed Web of Science ®Google Scholar
• The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters Version 12.0. 2022.
   Google Scholar
• Friedman ND, Kaye KS, Stout JE, et al. Health care–associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med. 2002;137(10):791–797.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Statist Med. 2000;19(3):335–351.
   PubMed Web of Science ®Google Scholar
• Horner C, Mushtaq S, Allen M, et al. Replacement of Enterococcus faecalis by Enterococcus faecium as the predominant enterococcus in UK bacteraemias. JAC Antimicrob Resist. 2021;3(4):dlab185.
   Google Scholar
• Laupland KB, Lyytikainen O, Sogaard M, International Bacteremia Surveillance Collaborative, et al. The changing epidemiology of Staphylococcus aureus bloodstream infection: a multinational population-based surveillance study. Clin Microbiol Infect. 2013;19(5):465–471.
   PubMed Web of Science ®Google Scholar
• Magill SS, O’Leary E, Janelle SJ, et al. Changes in prevalence of health care-associated infections in U.S. hospitals. N Engl J Med. 2018;379(18):1732–1744.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhao JY, Shan X, Chinese Group on Point-Prevalence Survey of Healthcare-Associated Infections, et al. A point-prevalence survey of healthcare-associated infection in fifty-two chinese hospitals. J Hosp Infect. 2017;95(1):105–111.
   PubMed Web of Science ®Google Scholar
• Webb BJ, Healy R, Majers J, et al. Prediction of bloodstream infection due to VancomycinResistant enterococcus in patients undergoing leukemia induction or hematopoietic Stem-Cell transplantation. Clin Infect Dis. 2017;64(12):1753–1759.
   PubMed Web of Science ®Google Scholar
• Das I, Gray J. Enterococcal bacteremia in children: a review of seventy-five episodes in a pediatric hospital. Pediatr Infect Dis J. 1998;17(12):1154–1158.
   PubMed Web of Science ®Google Scholar
• Friedman G, Stepensky P, Abu Ahmad W, et al. Enterococcal bacteremia in children with malignancies and Following hematopoietic stem cell transplantation: a 15-Year Single-Center experience. Pediatr Infect Dis J. 2020;39(4):318–324.
   PubMed Web of Science ®Google Scholar
• Šoprek S, Tambić Andrašević A. Antibiotic resistance surveillance in invasive isolates. In: Tambić-Andrašević A, Tambić T, editors. Antibiotic resistance in Croatia 2020. Zagreb: The Croatian Academy of Medical Sciences; 2021. p. 84–96.
   Google Scholar
• Sivaradjy M, Gunalan A, Priyadarshi K, et al. Increasing trend of vancomycin-resistant enterococci bacteremia in a tertiary care hospital of South India: a three-year prospective study. Indian J Crit Care Med. 2021;25(8):881–885.
   PubMed Web of Science ®Google Scholar
• De Angelis G, Cataldo MA, De Waure CD, et al. Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and Meta-analysis. J Antimicrob Chemother. 2014;69(5):1185–1192.
   PubMed Web of Science ®Google Scholar
• Mutters NT, Mersch-Sundermann V, Mutters R, et al. Control of the spread of Vancomycin-Resistant enterococci in hospitals. Dtsch Arztebl Int. 2013;110(43):725–731.
   PubMed Web of Science ®Google Scholar
• Eichel VM, Boutin S, Frank U, et al. Impact of discontinuing contact precautions and enforcement of basic hygiene measures on nosocomial vancomycin-resistant Enterococcus faecium transmission. J Hosp Infect. 2022;121:120–127.
   PubMed Web of Science ®Google Scholar